City

Beijing (2)

Condition

Carotid Atherosclerosis (2)

Carotid Intimal Medial Thickness 1 (1)

Overall Status

Completed (1)

Unknown status (1)

Sign in for free

Phase

phase 2/phase 3 (1)

phase 4 (1)

Sponsor

Peking University (1)

Wei Liu (1)

Collaborator

AstraZeneca (1)

Beijing Clinstech-med consulting Co., Ltd (1)

University of Washington (1)

Intervention

combination group (1)

lutein group (1)

normal lutein control group (1)

placebo (1)

rosuvastatin (5mg,10mg,20mg) (1)

rosuvastatin 5mg (1)

Study Documents

Intervention Type

dietary supplement (1)

drug (1)

Funder Type

Other (2)

Study Type

Interventional (2)

Carotid Atherosclerosis

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Carotid Atherosclerosis Trial in Beijing (Rosuvastatin (5mg,10mg,20mg), Rosuvastatin 5mg)

Unknown status

Carotid Atherosclerosis

Rosuvastatin (5mg，10mg，20mg)
Rosuvastatin 5mg

Beijing, Beijing, China

China-Japan Friendship Hospital

Aug 26, 2015

Carotid Atherosclerosis, Carotid Intimal Medial Thickness 1 Trial in Beijing (Placebo, Lutein group, Combination group)

Completed

Has Results

Carotid Atherosclerosis
Carotid Intimal Medial Thickness 1

Placebo
+3 more

Beijing, China

Haidian District

Jun 18, 2013